• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

σR/TMEM97 在视网膜神经节细胞变性中的作用。

σR/TMEM97 in retinal ganglion cell degeneration.

机构信息

Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA.

Department of Chemistry and Biochemistry, University of Texas at Austin, Austin, TX, 78712, USA.

出版信息

Sci Rep. 2022 Dec 1;12(1):20753. doi: 10.1038/s41598-022-24537-3.

DOI:10.1038/s41598-022-24537-3
PMID:36456686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9715665/
Abstract

The sigma 2 receptor (σR) was recently identified as an endoplasmic reticulum (ER) membrane protein known as transmembrane protein 97 (TMEM97). Studies have shown that σR/TMEM97 binding compounds are neuroprotective, suggesting a role of σR/TMEM97 in neurodegenerative processes. To understand the function of σR/TMEM97 in neurodegeneration pathways, we characterized ischemia-induced retinal ganglion cell (RGC) degeneration in TMEM97 mice and found that RGCs in TMEM97 mice are resistant to degeneration. In addition, intravitreal injection of a selective σR/TMEM97 ligand DKR-1677 significantly protects RGCs from ischemia-induced degeneration in wildtype mice. Our results provide conclusive evidence that σR/TMEM97 plays a role to facilitate RGC death following ischemic injury and that inhibiting the function of σR/TMEM97 is neuroprotective. This work is a breakthrough toward elucidating the biology and function of σR/TMEM97 in RGCs and likely in other σR/TMEM97 expressing neurons. Moreover, these findings support future studies to develop new neuroprotective approaches for RGC degenerative diseases by inhibiting σR/TMEM97.

摘要

σ2 受体(σR)最近被鉴定为一种内质网(ER)膜蛋白,称为跨膜蛋白 97(TMEM97)。研究表明,σR/TMEM97 结合化合物具有神经保护作用,提示 σR/TMEM97 在神经退行性过程中起作用。为了了解 σR/TMEM97 在神经退行性通路中的功能,我们对 TMEM97 小鼠的缺血诱导的视网膜神经节细胞(RGC)变性进行了表征,发现 TMEM97 小鼠的 RGC 对变性具有抗性。此外,选择性 σR/TMEM97 配体 DKR-1677 的玻璃体内注射可显著保护野生型小鼠的 RGC 免受缺血诱导的变性。我们的结果提供了确凿的证据,证明 σR/TMEM97 在缺血性损伤后促进 RGC 死亡,抑制 σR/TMEM97 的功能具有神经保护作用。这项工作是阐明 σR/TMEM97 在 RGC 中的生物学和功能的突破,并且可能在其他表达 σR/TMEM97 的神经元中也是如此。此外,这些发现支持未来通过抑制 σR/TMEM97 来开发针对 RGC 退行性疾病的新神经保护方法的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/8f022a8939c4/41598_2022_24537_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/8d4c8452f60d/41598_2022_24537_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/8cf56dfed968/41598_2022_24537_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/d4e734695683/41598_2022_24537_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/e5b3e85a86ab/41598_2022_24537_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/8f022a8939c4/41598_2022_24537_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/8d4c8452f60d/41598_2022_24537_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/8cf56dfed968/41598_2022_24537_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/d4e734695683/41598_2022_24537_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/e5b3e85a86ab/41598_2022_24537_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1241/9715665/8f022a8939c4/41598_2022_24537_Fig5_HTML.jpg

相似文献

1
σR/TMEM97 in retinal ganglion cell degeneration.σR/TMEM97 在视网膜神经节细胞变性中的作用。
Sci Rep. 2022 Dec 1;12(1):20753. doi: 10.1038/s41598-022-24537-3.
2
Bridging Known and Unknown Unknowns: From Natural Products and Their Mimics to Unmet Needs in Neuroscience.连接已知与未知的未知:从天然产物及其模拟物到神经科学中未满足的需求
Acc Chem Res. 2022 Sep 6;55(17):2397-2408. doi: 10.1021/acs.accounts.1c00773. Epub 2022 Aug 12.
3
Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.创伤性脑损伤后 sigma 2 受体/TMEM97 调节剂 (DKR-1677) 的神经保护作用。
ACS Chem Neurosci. 2019 Mar 20;10(3):1595-1602. doi: 10.1021/acschemneuro.8b00543. Epub 2018 Dec 3.
4
Neuroprotective Effects of σR/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease.σR/TMEM97 受体调节剂在亨廷顿病神经元模型中的神经保护作用。
ACS Chem Neurosci. 2022 Oct 5;13(19):2852-2862. doi: 10.1021/acschemneuro.2c00274. Epub 2022 Sep 15.
5
Structure-Affinity relationships of novel σR/TMEM97 ligands.新型 σR/TMEM97 配体的结构-亲和力关系。
Bioorg Chem. 2024 Apr;145:107191. doi: 10.1016/j.bioorg.2024.107191. Epub 2024 Feb 10.
6
Highly specific σR/TMEM97 ligand alleviates neuropathic pain and inhibits the integrated stress response.高特异性σR/TMEM97配体可减轻神经性疼痛并抑制整合应激反应。
bioRxiv. 2023 Oct 17:2023.04.11.536439. doi: 10.1101/2023.04.11.536439.
7
Highly specific σR/TMEM97 ligand FEM-1689 alleviates neuropathic pain and inhibits the integrated stress response.高度特异性 σR/TMEM97 配体 FEM-1689 可缓解神经性疼痛并抑制整合应激反应。
Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2306090120. doi: 10.1073/pnas.2306090120. Epub 2023 Dec 20.
8
Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.Sigma 2 受体/Tmem97 激动剂在小鼠中产生持久的抗神经病理性疼痛作用。
ACS Chem Neurosci. 2017 Aug 16;8(8):1801-1811. doi: 10.1021/acschemneuro.7b00200. Epub 2017 Jul 13.
9
Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σR/TMEM97 ligands.四氢异喹啉-2-烷基苯酮作为选择性 σR/TMEM97 配体的合成、结合和功能性质。
Eur J Med Chem. 2021 Jan 1;209:112906. doi: 10.1016/j.ejmech.2020.112906. Epub 2020 Oct 7.
10
High-Content Microfluidic Screening Platform Used To Identify σ2R/Tmem97 Binding Ligands that Reduce Age-Dependent Neurodegeneration in C. elegans SC_APP Model.高通量微流控筛选平台用于鉴定 σ2R/Tmem97 结合配体,减少 C. elegans SC_APP 模型中与年龄相关的神经退行性变。
ACS Chem Neurosci. 2018 May 16;9(5):1014-1026. doi: 10.1021/acschemneuro.7b00428. Epub 2018 Feb 23.

引用本文的文献

1
Neurosteroids Progesterone and Dehydroepiandrosterone: Molecular Mechanisms of Action in Neuroprotection and Neuroinflammation.神经甾体孕酮和脱氢表雄酮:神经保护和神经炎症中的分子作用机制
Pharmaceuticals (Basel). 2025 Jun 23;18(7):945. doi: 10.3390/ph18070945.
2
Catalpol Protects Against Retinal Ischemia Through Antioxidation, Anti-Ischemia, Downregulation of β-Catenin, VEGF, and Angiopoietin-2: In Vitro and In Vivo Studies.梓醇通过抗氧化、抗缺血、下调β-连环蛋白、血管内皮生长因子和血管生成素-2对视网膜缺血起到保护作用:体外和体内研究
Int J Mol Sci. 2025 Apr 24;26(9):4019. doi: 10.3390/ijms26094019.
3
TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axis.

本文引用的文献

1
Structures of the σ receptor enable docking for bioactive ligand discovery.σ受体的结构有助于对接以发现生物活性配体。
Nature. 2021 Dec;600(7890):759-764. doi: 10.1038/s41586-021-04175-x. Epub 2021 Dec 8.
2
A proteome-wide map of 20(S)-hydroxycholesterol interactors in cell membranes.细胞膜中 20(S)-羟基胆固醇相互作用蛋白组的全蛋白质图谱。
Nat Chem Biol. 2021 Dec;17(12):1271-1280. doi: 10.1038/s41589-021-00907-2. Epub 2021 Nov 19.
3
Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma.
跨膜蛋白97通过连环蛋白δ2-解聚素金属蛋白酶10轴调控视网膜色素上皮细胞的部分上皮-间质转化。
Mol Ther Nucleic Acids. 2025 Jan 21;36(1):102460. doi: 10.1016/j.omtn.2025.102460. eCollection 2025 Mar 11.
4
Sigma-2 receptor modulator CT1812 alters key pathways and rescues retinal pigment epithelium (RPE) functional deficits associated with dry age-related macular degeneration (AMD).西格玛-2受体调节剂CT1812改变关键信号通路,并挽救与干性年龄相关性黄斑变性(AMD)相关的视网膜色素上皮(RPE)功能缺陷。
Sci Rep. 2025 Feb 10;15(1):4256. doi: 10.1038/s41598-025-87921-9.
5
2-(Piperidin-3-yl)phthalimides reduce classical markers of cellular inflammation in LPS-challenged RAW 264.7 cells and also demonstrate potentially relevant sigma and serotonin receptor affinity in membrane preparations.2-(哌啶-3-基)邻苯二甲酰亚胺降低 LPS 刺激的 RAW 264.7 细胞中经典的细胞炎症标志物,并且在膜制剂中也表现出潜在相关的 sigma 和 5-羟色胺受体亲和力。
Bioorg Med Chem Lett. 2024 Sep 15;110:129885. doi: 10.1016/j.bmcl.2024.129885. Epub 2024 Jul 10.
6
Transmembrane protein TMEM97 and epigenetic reader BAHCC1 constitute an axis that supports pro-inflammatory cytokine expression.跨膜蛋白 TMEM97 和表观遗传阅读器 BAHCC1 构成了一个支持促炎细胞因子表达的轴。
Cell Signal. 2024 Apr;116:111069. doi: 10.1016/j.cellsig.2024.111069. Epub 2024 Jan 28.
7
Highly specific σR/TMEM97 ligand FEM-1689 alleviates neuropathic pain and inhibits the integrated stress response.高度特异性 σR/TMEM97 配体 FEM-1689 可缓解神经性疼痛并抑制整合应激反应。
Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2306090120. doi: 10.1073/pnas.2306090120. Epub 2023 Dec 20.
8
Highly specific σR/TMEM97 ligand alleviates neuropathic pain and inhibits the integrated stress response.高特异性σR/TMEM97配体可减轻神经性疼痛并抑制整合应激反应。
bioRxiv. 2023 Oct 17:2023.04.11.536439. doi: 10.1101/2023.04.11.536439.
9
Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases.Sigma-2 受体——从基础生物学到治疗靶点:关注与年龄相关的退行性疾病。
Int J Mol Sci. 2023 Mar 26;24(7):6251. doi: 10.3390/ijms24076251.
普瑞巴林通过 sigma-1 受体激动剂对实验性青光眼模型中视网膜神经节细胞的神经保护作用。
Sci Rep. 2021 Nov 9;11(1):21975. doi: 10.1038/s41598-021-01077-w.
4
TMEM97 ablation aggravates oxidant-induced retinal degeneration.TMEM97 消融加剧氧化应激诱导的视网膜变性。
Cell Signal. 2021 Oct;86:110078. doi: 10.1016/j.cellsig.2021.110078. Epub 2021 Jul 7.
5
Diabetes Exacerbates the Intraocular Pressure-Independent Retinal Ganglion Cells Degeneration in the DBA/2J Model of Glaucoma.糖尿病加剧 DBA/2J 型青光眼模型中眼压非依赖性视网膜神经节细胞变性。
Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):9. doi: 10.1167/iovs.62.9.9.
6
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.近年来,作为细胞毒剂的 sigma 受体配体的发展进展:药物化学视角。
J Med Chem. 2021 Jun 24;64(12):7926-7962. doi: 10.1021/acs.jmedchem.0c02265. Epub 2021 Jun 2.
7
The Sigma-2 receptor / transmembrane protein 97 (σ2R/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice.Sigma-2 受体/跨膜蛋白 97(σ2R/TMEM97)调节剂 JVW-1034 可减少雄性小鼠的重度饮酒和相关疼痛状态。
Neuropharmacology. 2021 Feb 15;184:108409. doi: 10.1016/j.neuropharm.2020.108409. Epub 2020 Nov 20.
8
The Biological Function of Sigma-2 Receptor/TMEM97 and Its Utility in PET Imaging Studies in Cancer.西格玛-2受体/TMEM97的生物学功能及其在癌症PET成像研究中的应用
Cancers (Basel). 2020 Jul 13;12(7):1877. doi: 10.3390/cancers12071877.
9
Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.神经保护策略治疗视网膜神经节细胞变性:现状与挑战。
Int J Mol Sci. 2020 Mar 25;21(7):2262. doi: 10.3390/ijms21072262.
10
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease.一项针对新型阿尔茨海默病治疗候选药物sigma-2受体复合物变构拮抗剂CT1812的1期临床试验。
Alzheimers Dement (N Y). 2019 Jan 23;5:20-26. doi: 10.1016/j.trci.2018.11.001. eCollection 2019.